AAAAAA

   
Results: 1-25 | 26-50 | 51-59 |
Results: 51-59/59
Hormone replacement therapy and plasma homocysteine levels
Authors: Van Baal, WM Smolders, RGV Van der Mooren, MJ Teerlink, T Kenemans, P
Citation: Wm. Van Baal et al., Hormone replacement therapy and plasma homocysteine levels, OBSTET GYN, 94(4), 1999, pp. 485-491
Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapy
Authors: Van de Weijer, PHM Barentsen, R De Vries, M Kenemans, P
Citation: Phm. Van De Weijer et al., Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapy, OBSTET GYN, 93(4), 1999, pp. 551-557
Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations
Authors: Zweemer, RP Shaw, PA Verheijen, RMH Ryan, A Berchuck, A Ponder, BAJ Risch, H McLaughlin, JR Narod, SA Menko, FH Kenemans, P Jacobs, IJ
Citation: Rp. Zweemer et al., Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations, J CLIN PATH, 52(5), 1999, pp. 372-375
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
Authors: van Baal, WM Kenemans, P Emeis, JJ Schalkwijk, CG Mijatovic, V van der Mooren, MJ Vischer, UM Stehouwer, CDA
Citation: Wm. Van Baal et al., Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women, FERT STERIL, 71(4), 1999, pp. 663-670
Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules
Authors: van Baal, WM Emeis, JJ Kenemans, P Kessel, H Peters-Muller, ERA Schalkwijk, CG van der Mooren, MJ Stehouwer, CDA
Citation: Wm. Van Baal et al., Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules, EUR J CL IN, 29(11), 1999, pp. 913-921
Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausalwomen
Authors: van Baal, WM Kenemans, P Stehouwer, CDA Peters-Muller, ERA van Vugt, JMG van der Mooren, MJ
Citation: Wm. Van Baal et al., Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausalwomen, AM J OBST G, 181(6), 1999, pp. 1365-1373
CA 125 as predictor of response to chemotherapy in ovarian cancer
Authors: Verheijen, RHM Van Kamp, GJ Kenemans, P
Citation: Rhm. Verheijen et al., CA 125 as predictor of response to chemotherapy in ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 21-27
Women's expectations and acceptance of cyclic induced HRT bleeds
Authors: van de Weijer, PHM Barentsen, R Kenemans, P
Citation: Phm. Van De Weijer et al., Women's expectations and acceptance of cyclic induced HRT bleeds, MATURITAS, 30(3), 1998, pp. 257-263
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women
Authors: Mijatovic, V Netelenbos, C van der Mooren, MJ de Valk-de Roo, GW Jakobs, C Kenemans, P
Citation: V. Mijatovic et al., Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women, FERT STERIL, 70(6), 1998, pp. 1085-1089
Risultati: 1-25 | 26-50 | 51-59 |